Disease
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 28, 2026 · JOURNAL ARTICLE
Journal of Translational Medicine
A comprehensive narrative review synthesising epidemiology, pathophysiology, and therapeutic evidence for ME/CFS, offering clinical and research direction rather than reporting original data or a single definitive trial.
AUG 11, 2026 · JOURNAL ARTICLE
Clinical Neurology and Neuroscience
This is a clinical review of a rare disease with uncertain etiology; it synthesizes existing knowledge rather than presenting new experimental evidence, and the source explicitly states the causal mechanism remains debated and uncertain.
AUG 1, 2026 · JOURNAL ARTICLE
Trends in Biotechnology
An opinion article addressing scientific and translational challenges in CRISPR therapeutics rather than reporting new empirical evidence or clinical outcomes.
JUL 30, 2026 · REVIEW
Medical Science
A narrative review synthesizing preclinical evidence and early clinical trial data to identify research directions, not reporting a primary empirical result with a defined effect size or comparator.
JUL 27, 2026 · JOURNAL ARTICLE
Skeletal Muscle
A comprehensive narrative review synthesizing current understanding of DMD pathophysiology, clinical management, and therapeutic landscape without presenting new original data or clinical trial results.
JUL 16, 2026 · JOURNAL ARTICLE
Epilepsy & Behavior
A comprehensive narrative review synthesizing mechanistic understanding and therapeutic evidence across multiple modalities for a rare monogenic encephalopathy, intended to inform clinical practice and research strategy.